A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease

Thyroid

Volumn 12, Issue 12, 2002, Pages 1129-1135

  Tomer, Yaron ^a   Concepcion, Erlinda ^a   Greenberg, David A ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ALLELE; ARTICLE; CAUCASIAN; CHROMOSOME 20Q; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HUMAN; LINKAGE ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0036959340     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072502321085234     Document Type: Article

References (36)

1. Jacobson DL, Gange SJ, Rose NR, Graham NM 1997 Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223-243.
2. Davies TF 2000 Graves' diseases: Pathogenesis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text. Lippincott Williams & Wilkins, Philadelphia, pp. 518-530.
3. Tomer Y, Davies TF 1993 Infection, thyroid disease and autoimmunity. Endoc Rev 14:107-120.
4. Tomer Y, Davies TF 2000 The genetics of familial and nonfamilial hyperthyroid Graves' disease. In: Rapoport B, McLachlan SM (eds) Graves' Disease: Pathogenesis and Treatment. Kluwer Academic Publishers, Boston, pp. 19-41.
5. Vyse TJ, Todd JA 1996 Genetic analysis of autoimmune disease. Cell 85:311-318.
6. Villanueva RB, Inzerillo AM, Tomer Y, Barbesino G, Meltzer M, Concepcion ES, Greenberg DA, Maclaren N, Sun ZS, Zhang DM, Tucci S, Davies TF 2000 Limited genetic susceptibility to severe graves' ophthalmopathy: No role for ctla-4 and evidence for an environmental etiology. Thyroid 10:791-798.
7. Brix TH, Christensen K, Holm NV, Harvald B, Hegedus L 1998 A population-based study of Graves' diseases in Danish twins. Clin Endocrinol 48:397-400.
8. Brix TH, Kyvik KO, Christensen K, Hegedus L 2001 Evidence for a major role of heredity in Graves' disease: A population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 86:930-934.
9. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1998 A new Graves disease-susceptibility locus maps to chromosome 20q11.2. Am J Hum Genet 63:1749-1756.
10. Tomer Y, Barbesino G, Greenberg DA, Concepcion ES, Davies TF 1999 Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: Evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab 84:4656-4664.
11. Tomer Y, Greenberg DA, Concepcion ES, Davies TF 2002 Genetic studies in a cohort of 102 multiplex autoimmune thyroid disease families with 540 individuals. The 84th Annual Meeting of the Endocrine Society. San Francisco, California.
12. Pearce SH, Vaidya B, Imrie H, Perros P, Kelly WF, Toft AD, McCarthy MI, Young ET, Kendall-Taylor P 1999 Further evidence for a susceptibility locus on chromosome 20q13.11 in families with dominant transmission of Graves disease [letter]. Am J Hum Genet 65:1462-1465.
13. van Kooten C, Banchereau J 1997 Functional role of CD40 and its ligand. Int Arch Allergy Immunol 113:393-399.
14. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F, Saeland S 1994 The CD40 antigen and its ligand. Annu Rev Immunol 12:881-922.
15. Tomer Y, Greenberg DA, Barbesino G, Concepcion ES, Davies TF 2001 CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab 86:1687-1693.
16. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES 1996 Parametric and nonparametric linkage analysis: A unified multipoint approach. Am J Hum Genet 58:1347-1363.
17. Morton NE 1956 The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type. Am J Hum Genet 8:80-96.
18. Hodge SE, Anderson CE, Neiswanger K, Sparkes RS, Rimoin DL 1983 The search for heterogeneity in insulin dependent diabetes mellitus (IDDM): Linkage studies, two-locus models, and genetic heterogeneity. Am J Hum Genet 35:1139-1155.
19. Woolf B 1955 On estimating the relation between blood group and disease. Ann Hum Genet 19:251-253.
20. Spielman RS, McGinnis RE, Ewens WJ 1993 Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus. Am J Hum Genet 52:506-516.
21. Volpe R 1985 Autoimmune thyroid disease. In: Volpe R (ed) Autoimmunity and Endocrine Disease. Marcel Dekker, New York, pp. 109-285.
22. Burek CL, Hoffman WH, Rose NR 1982 The presence of thyroid autoantibodies in children and adolescents with AITD and in their siblings and parents. Clin Immunol Immunopathol 25:395-404.
23. Carayanniotis G, Masters SR, Noelle RJ 1997 Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421-426.
24. Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ 2000 CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease. J Immunol 165:6606-6611.
25. Ban Y, Davies TF, Greenberg DA, Concepcion ES, Tomer Y 2002 Potential role of HLA-DR-74 Arginine in the genetic susceptibility to Graves' disease. The 84th Annual Meeting of the Endocrine Society San Francisco, California, June.
26. Sawai Y, DeGroot LJ 2000 Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab 85:1176-1179.
27. Kishimoto K, Dong VM, Issazadeh S, Fedoseyeva EV, Waaga AM, Yamada A, Sho M, Benichou G, Auchincloss H, Jr., Grusby MJ, Khoury SJ, Sayegh MH 2000 The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. J Clin Invest 106:63-72.
28. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Noelle RJ 1996 Immune regulation by CD40 and its ligand GP39. Annu Rev Immunol 14:591-617.
29. Kozak M 1991 An analysis of vertebrate mRNA sequences: intimations of translational control. J Cell Biol 115:887-903.
30. Kozak M 1991 Structural features in eukaryotic mRNAs that modulate the initiation of translation. J Biol Chem 266:19867-19870.
31. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF 2002 Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J Clin Endocrinol Metab 87:404-407.
32. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ 1994 The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 15:406-411.
33. Faure GC, Bensoussan-Lejzerowicz D, Bene MC, Aubert V, Leclere J 1997 Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells. Clin Immunol Immunopathol 84:212-215.
34. Metcalfe RA, McIntosh RS, Marelli-Berg F, Lombardi G, Lechler R, Weetman AP 1998 Detection of CD40 on human thyroid follicular cells: analysis of expression and function. J Clin Endocrinol Metab 83:1268-1274.
35. Smith TJ, Sciaky D, Phipps RP, Jennings TA 1999 CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases [In Process Citation]. Thyroid 9:749-755.
36. Davies TF, Piccinini LA, Roman SH, Hirose W, Neufeld DS 1988 Role of MHC class II antigen expression in thyroid autoimmunity. Ann NY Acad Sci 546:151-163.